Cite

HARVARD Citation

    Byun, J. et al. (2020). Incorporating hematopoietic stem-cell transplantation after second-line carfilzomib-lenalidomide-dexamethasone (KRd). Therapeutic advances in hematology. p. . [Online]. 
  
Back to record